ARA-290 Side Effects
ARA-290 is a tissue-protective erythropoietin analogue being studied for neuropathy, pain, and metabolic conditions. It is generally well tolerated in clinical studies completed to date.
This page is for educational purposes only and is not medical advice. Side effects vary between individuals. All protocols at Peptides Thailand are individually prescribed by licensed physicians. Contact your doctor with any concerns during treatment.
ARA-290 has been studied in phase 2 clinical trials for neuropathic pain, providing a reasonable early human safety profile.
Side effects to be aware of
Injection site reactions
CommonMild redness or swelling at the injection site, common to subcutaneous injections.
Mild fatigue
UncommonOccasionally reported, transient.
Who is a good candidate?
- Adults with peripheral neuropathy or painful neuropathic conditions under physician supervision
- Patients with haematological conditions without specialist clearance
Contraindications
Your physician screens for these conditions before prescribing. Do not attempt to self-prescribe.
- Active haematological conditions (erythropoietin class - discuss with physician)
- Pregnancy and breastfeeding
- Known hypersensitivity to erythropoietin analogues
When to contact your physician
- Nausea, vomiting, or digestive symptoms that are severe or do not ease within two weeks
- Any chest pain, palpitations, or significant change in heart rate
- Signs of allergic reaction: rash, hives, swelling of the face or throat, or difficulty breathing
- Injection site reactions that worsen, spread, or do not resolve within 72 hours
- Any new or worsening symptoms that concern you, regardless of whether they seem related to your protocol
If you are ever unsure, contact your physician. That is what they are there for.
Learn more
Have questions about ARA-290?
Message our team on WhatsApp. We typically reply within minutes.
Message us on WhatsApp